Syneron Medical Ltd (ELOS) Tops Q2 EPS by 1c

Syneron Medical Ltd (NASDAQ: ELOS) reported Q2 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $68.1 million versus the consensus estimate of $66.92 million.

For earnings history and earnings-related data on Syneron Medical Ltd (ELOS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Truist Financial Corp. (TFC) Tops Q2 EPS by 15c
• Travelers (TRV) Tops Q2 EPS by $4.92